PR

Prava Ravishankar

Active Director Director DIN 09524250
DIN 09524250 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Prava Ravishankar

Data last updated:

Prava Ravishankar is a Director at Gloxiniaa Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals.

DIN 09524250
Primary Designation Director
Industry Chemicals
First Appointment 02 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Mar 20222022Active

Board colleagues of Prava Ravishankar

Directorship timeline

Open interactive timeline →
Gloxiniaa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prava Ravishankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prava Ravishankar

Prava Ravishankar currently holds 1 directorship: Gloxiniaa Pharmaceuticals Private Limited (Director, since 02 Mar 2022).

Prava Ravishankar was first appointed on 02 Mar 2022 as Director at Gloxiniaa Pharmaceuticals Private Limited.

The current boards of Prava Ravishankar's companies include Sreeramulu Sham Kumar Sekandlapuram (Gloxiniaa Pharmaceuticals Private Limited), Srinivas Vemula (Gloxiniaa Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available